A history of opioid addiction would be required to be displayed in medical records of individuals who have consented. It would also be shared with clinicians and pharmacists, according to a bill approved by the US Senate.
The Senate passed the so-called "Jessie's Law" (S. 581) by unanimous consent on August 3 during a marathon session to tie up loose ends before legislators broke for their previously delayed summer recess. The unanimous consent procedure eliminated the need for debate or a vote.
The bill followed a remarkably fast track after it was introduced in March by Democratic Senator Joe Manchin of West Virginia. A companion proposal was introduced at the same time in the US House of Representatives by two Michigan lawmakers, Democrat Debbie Dingell and Republican Tim Walberg.
The law is named for Jessie Grubb, a recovering addict who experienced relapse and overdosed after being given a large quantity of opioids following a surgical procedure by a clinician who said he was unaware of her history.
"We must ensure physicians and other medical professionals have full knowledge of a patient's previous opioid addiction when determining appropriate medical care," said Manchin, in a statement issued after the Senate approval.
The bill calls on the Secretary of Health and Human Services to develop standards that could be used by hospitals and physicians to "prominently" display a patient's history of opioid addiction in his or her medical record, but only if the patient has consented to providing the history to a clinician.
The idea is that the opioid addiction history would be considered on par with allergies and other contraindications when a clinician is considering prescribing an opioid. The proposal states that the information should be available to all providers, including physicians, nurses, and pharmacists.
"Jessie's Law" still needs to be taken up by the House.
The AOA has approved as eligible for AOA Addiction Medicine subspecialty certification those osteopathic physicians who hold the following credentials:
Applicants who meet these two requirements will be granted subspecialty/CAQ certification in Addiction Medicine, with a requirement that Diplomates maintain their certification through the AOA's Addiction Medicine Osteopathic Continuous Certification (OCC) process.
Once certified, examination will occur at the appropriate interval based on the date of initial certification or re-certification by ABAM. Other OCC requirements will apply as adopted by the Bureau of Osteopathic Specialists (BOS). Please note that, at this time, the OCC process is under review by the BOS and AOA Board of Trustees (BOT). Details will be forthcoming.
The application fee is $295.
Apply at AOCCAM.ORG
You may also contact AOAAM's Executive Director, Nina Vidmer, at firstname.lastname@example.org or 708-572-8006 if you have any questions.
The American Osteopathic Academy of Addiction Medicine (AOAAM) and the American Osteopathic Association (AOA) held a meeting on April 7, 2017 to discuss the mechanism to attain a subspecialty certification in addiction medicine.
The meeting was a follow-up to the AOA resolution that was passed on April 12, 2016 that provides DOs who are ABAM diplomates with a process to attain an AOA subspecialty certification in addiction medicine.
Osteopathic physicians who are ABAM diplomates have 3 possibilities for certification in addiction medicine:
The AOA recognizes that the opioid epidemic has had a tremendous impact on families, and therefore they are considering a practice pathway for the future to allow for even more DOs to combat the increase of substance use disorder among our patients.
Attached are slide sets from the AOA and ABAM that outline the pathway to certification. We will keep our members apprised of any news as it becomes available.
Fighting substance use disorders is a big challenge for American veterans and their communities. AOAAM past President, Anthony Dekker, DO, was a recent contributor to the article in Media Planet, “Help is on the Way for Veterans Caught in the Opioid Crisis.” Read the article.
Apr 17, 2017 Clinical Essentials from MMWR Morb Mortal Wkly Rep
Why this matters
Somerville NJ, O'Donnell J, Gladden RM, Zibbell JE, Green TC, Younkin M, Ruiz S, BabakhanlouChase H, Chan M, Callis BP, Kuramoto-Crawford J, Nields HM, Walley AY. Characteristics of Fentanyl Overdose - Massachusetts, 2014-2016. MMWR Morb Mortal Wkly Rep. 2017;66(14):382-386. doi: 10.15585/mmwr.mm6614a2. PMID: 28406883
© 2016 Univadis International, Inc. All rights reserved.
Psychological Consequences of the American Civil War
Author: R. Gregory Lande
The conclusion of America's Civil War set off an ongoing struggle as a fractured society suffered the psychological consequences of four years of destruction, deprivation and distrust. Veterans experienced climbing rates of depression, suicide, mental illness, crime, and alcohol and drug abuse. Survivors, leery of conventional medicine and traditional religion, sought out quacks and spiritualists as cult memberships grew. This book provides a comprehensive account of the war-weary fighting their mental demons.
Paperback: 256 pages / Publisher: McFarland (December 20, 2016) / Language: English
ISBN-10: 1476667373 / ISBN-13: 978-1476667379
Click here to view the October 2016 Addiction Education News - COPE
Click to view SAMHSA’s presentation on “Understanding the Buprenorphine Final Rule for a Patient Limit of 275”.
Physicians who have prescribed buprenorphine to 100 patients for at least one year can now increase their patient limits to 275 under new federal regulations. Read CSAT's Dear Colleague Letter (PDF | 234 KB) on the new rule.
The Understanding the Final Rule for a Patient Limit of 275 (PDF | 163 KB) guidance document will help you determine whether you are eligible to request the new, higher limit on the patients that you may treat based on your credentials or features of your practice setting. You may also review the final rule in the Federal Register for further information.
If you wish to be considered for the higher limit please complete the online Waiver Notification Form SMA-167. SAMHSA reviews applications within 45 days of receipt. For more information, send an email to email@example.com or call 866-BUP-CSAT (866-287-2728).
The Senate earlier this week passed the Comprehensive Addiction and Recovery Act (CARA).
The bill, which focuses on treating substance use disorder as a chronic illness rather than a criminal offense, expands education and prevention efforts, strengthens prescription drug monitoring programs, and increases first responder access to naloxone. The bill also allows nurse practitioners and physician assistants to prescribe buprenorphine with some restrictions.
AOAAM Online CME
Waiver Eligibility Training
The mission of the American Osteopathic Academy of Addiction Medicine is
to improve the health of individuals and families burdened with the
disease of addiction.
PAY DUES ONLINE
SEARCH FOR MEMBERS